Clover Health Corp (CLOV) saw its stock price plummet by 5.35% during intraday trading on Friday.
The decline follows the company's release of mixed quarterly financial results and forward-looking guidance. Clover Health reported a quarterly adjusted loss of 10 cents per share for the period ended September 30, 2025, with revenue growing 47.4% year-over-year to $487.71 million. However, the company posted a substantial quarterly loss of $49.32 million, representing a deterioration from the same quarter last year.
Investors reacted negatively to the company's full-year 2026 revenue guidance of $2.81 billion to $2.92 billion, indicating concerns about continued losses despite revenue growth and uncertainty over the path to profitability.
Comments